Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DIA vs MRNA✓SelectedUSD · MRNADIA vs MRNA performance historyLatest closeAs of-1.62%11/17
Stock and ETF performance explorer

DIA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+140.3%
MRNA return
+840.0%
Excess return
-699.7%
Maximum drawdown
-36.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.6%-3.9%+2.3%-1.5%
7D-2.8%-17.6%+14.8%-2.3%
30D-2.3%-5.1%+2.9%-2.2%
3M-4.7%+220.8%-225.5%-9.4%
6M+3.1%+321.7%-318.6%-3.4%
YTD+6.7%+601.3%-594.5%-2.4%
1Y+10.4%+735.2%-724.8%+0.1%
3Y+52.0%+170.5%-118.6%+41.5%
5Y+53.7%-14.6%+68.3%+45.4%
All+140.3%+840.0%-699.7%+116.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling